Frequency of microbial spectrum of spontaneous bacterial peritonitis in established cirrhosis liver

Amjad Zaman1, Rahida Kareem, Rashid Mahmood

  • 1Department of Physiology, Khyber Girls Medical College, Peshawar, Pakistan. dramjadpk@hotmail.com

Abstract

Insights

Spontaneous bacterial peritonitis (SBP) is a common complication in liver cirrhosis patients. Escherichia coli is the most frequent cause, highlighting the need for population-specific antibiotic strategies.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Microbiology

Background:

  • Spontaneous bacterial peritonitis (SBP) is a frequent and serious complication in patients with liver cirrhosis and ascites.
  • SBP is associated with high mortality rates, necessitating prompt empiric antibiotic therapy.
  • Understanding the local microbial spectrum is crucial for effective SBP management before culture results are available.

Purpose of the Study:

  • To determine the microbial spectrum of spontaneous bacterial peritonitis (SBP) in patients with liver cirrhosis and ascites.
  • To identify the most common causative organisms of SBP in a specific population.
  • To inform the selection of appropriate empiric antibiotic regimens for SBP.

Main Methods:

  • A descriptive study involving 50 consecutive patients with liver cirrhosis and ascites at Hayatabad Medical Complex, Peshawar.
  • Ascitic fluid was collected for bacterial culture, biochemical, and cytological examination.
  • Patients were included based on suspicion or risk factors for SBP.

Main Results:

  • Spontaneous bacterial peritonitis (SBP) or its variants were diagnosed in 56% of patients (28 out of 50).
  • Escherichia coli was the most frequently isolated organism (66.66%), followed by Streptococcus pneumoniae (16.66%).
  • Culture-positive SBP occurred in 12 cases, with E. coli dominating the microbial profile.

Conclusions:

  • Spontaneous bacterial peritonitis (SBP) and its variants are common in liver cirrhosis with ascites.
  • Escherichia coli is the predominant pathogen causing SBP in this population.
  • Knowledge of the local microbial spectrum is vital for guiding empiric antibiotic therapy in SBP.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...